Muriel de La Dure-Molla

Muriel de La Dure-Molla

Auto-generated profile, based on publicly available information

Muriel de La Dure-Molla

Reference Center for Oral and Dental Rare Diseases APHP, ORARES, Rothschild Hospital Paris France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
IBIsabelle Bailleul-Forestier
Isabelle Bailleul-Forestier
MMMuriel Molla
Muriel Molla
AVAlain Verloes
Alain Verloes
ABAriane Berdal
Ariane Berdal

1 July 2013 in The American Journal of Pathology
Verified
Journal Article
Open access
KJKatia Jedeon
Katia Jedeon
MDMuriel De la Dure-Molla
Muriel De la Dure-Molla
SBSteven J. Brookes
Steven J. Brookes
SLSophia Loiodice
Sophia Loiodice
CMClémence Marciano
Clémence Marciano
SBSylvie Babajko
Sylvie Babajko
Endocrine-disrupting chemicals (EDCs), including bisphenol A (BPA), are environmental ubiquitous pollutants and associated with a growing health concern. Anecdotally, molar incisor hypomineralization (MIH) is increasing concurrently with EDC-related conditions, which has led us to investigate the effect of BPA on amelogenesis. Rats were exposed daily to BPA from conception until day 30 or 100. At day 30, BPA-affected enamel exhibited hypomineralization similar to human MIH. Scanning electron microscopy and elemental analysis revealed an abnormal accumulation of organic material in erupted enamel. BPA-affected enamel had an abnormal accumulation of exogenous albumin in the maturation stage. Quantitative real-time PCR, Western blotting, and luciferase reporter assays revealed increased expression of enamelin but decreased expression of kallikrein 4 (protease essential for removing enamel proteins) via transcriptional regulation. Data suggest that BPA exerts its effects on amelogenesis by disrupting normal protein removal from the enamel matrix. Interestingly, in 100-day-old rats, erupting incisor enamel was normal, suggesting amelogenesis is only sensitive to MIH-causing agents during a specific time window during development (as reported for human MIH). The present work documents the first experimental model that replicates MIH and presents BPA as a potential causative agent of MIH. Because human enamel defects are irreversible, MIH may provide an easily accessible marker for reporting early EDC exposure in humans.

13 August 2014 in European Journal of Human Genetics
Verified
Journal Article
Closed access
MDMuriel de La Dure-Molla
Muriel de La Dure-Molla
BFBenjamin Philippe Fournier
Benjamin Philippe Fournier
ABAriane Berdal
Ariane Berdal

23 February 2013 in Nephron Physiology
Verified
Journal Article
Open access
PDF file
GJGraciana Jaureguiberry
Graciana Jaureguiberry
MDMuriel De la Dure-Molla
Muriel De la Dure-Molla
David ParryDavid Parry
David Parry
MQMickael Quentric
Mickael Quentric
NHNina Himmerkus
Nina Himmerkus
RKRobert Kleta
Robert Kleta
Background/Aims: Calcium homeostasis requires regulated cellular and interstitial systems interacting to modulate the activity and movement of this ion. Disruption of these systems in the kidney results in nephrocalcinosis and nephrolithiasis, important medical problems whose pathogenesis is incompletely understood. Methods: We investigated 25 patients from 16 families with unexplained nephrocalcinosis and characteristic dental defects (amelogenesis imperfecta, gingival hyperplasia, impaired tooth eruption). To identify the causative gene, we performed genome-wide linkage analysis, exome capture, next-generation sequencing, and Sanger sequencing. Results: All patients had bi-allelic FAM20A mutations segregating with the disease; 20 different mutations were identified. Conclusions: This au-tosomal recessive disorder, also known as enamel renal syndrome, of FAM20A causes nephrocalcinosis and amelogenesis imperfecta. We speculate that all individuals with biallelic FAM20A mutations will eventually show nephrocalcinosis.

26 October 2015 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MPMegana K Prasad
Megana K Prasad
VGVéronique Geoffroy
Véronique Geoffroy
SVSerge Vicaire
Serge Vicaire
BJBernard Jost
Bernard Jost
MDMichael Dumas
Michael Dumas
Agnès Bloch-ZupanAgnès Bloch-Zupan
Agnès Bloch-Zupan
Background Orodental diseases include several clinically and genetically heterogeneous disorders that can present in isolation or as part of a genetic syndrome. Due to the vast number of genes implicated in these disorders, establishing a molecular diagnosis can be challenging. We aimed to develop a targeted next-generation sequencing (NGS) assay to diagnose mutations and potentially identify novel genes mutated in this group of disorders. Methods We designed an NGS gene panel that targets 585 known and candidate genes in orodental disease. We screened a cohort of 101 unrelated patients without a molecular diagnosis referred to the Reference Centre for Oro-Dental Manifestations of Rare Diseases, Strasbourg, France, for a variety of orodental disorders including isolated and syndromic amelogenesis imperfecta (AI), isolated and syndromic selective tooth agenesis (STHAG), isolated and syndromic dentinogenesis imperfecta, isolated dentin dysplasia, otodental dysplasia and primary failure of tooth eruption. Results We discovered 21 novel pathogenic variants and identified the causative mutation in 39 unrelated patients in known genes (overall diagnostic rate: 39%). Among the largest subcohorts of patients with isolated AI (50 unrelated patients) and isolated STHAG (21 unrelated patients), we had a definitive diagnosis in 14 (27%) and 15 cases (71%), respectively. Surprisingly, COL17A1 mutations accounted for the majority of autosomal-dominant AI cases. Conclusions We have developed a novel targeted NGS assay for the efficient molecular diagnosis of a wide variety of orodental diseases. Furthermore, our panel will contribute to better understanding the contribution of these genes to orodental disease. Trial registration numbers NCT01746121 and NCT02397824.

29 August 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
MDMuriel de La Dure‐Molla
Muriel de La Dure‐Molla
BFBenjamin Philippe Fournier
Benjamin Philippe Fournier
MCMaria Cristina Manzanares Céspedes
Maria Cristina Manzanares Céspedes
AAAna Carolina Acevedo
Ana Carolina Acevedo
RHRaoul C. Hennekam
Raoul C. Hennekam
Agnès Bloch-ZupanAgnès Bloch-Zupan
Agnès Bloch-Zupan
Dental anomalies occur frequently in a number of genetic disorders and act as major signs in diagnosing these disorders. We present definitions of the most common dental signs and propose a classification usable as a diagnostic tool by dentists, clinical geneticists, and other health care providers. The definitions are part of the series Elements of Morphology and have been established after careful discussions within an international group of experienced dentists and geneticists. The classification system was elaborated in the French collaborative network “TÊTECOU” and the affiliated O‐Rares reference/competence centers. The classification includes isolated and syndromic disorders with oral and dental anomalies, to which causative genes and main extraoral signs and symptoms are added. A systematic literature analysis yielded 408 entities of which a causal gene has been identified in 79%. We classified dental disorders in eight groups: dental agenesis, supernumerary teeth, dental size and/or shape, enamel, dentin, dental eruption, periodontal and gingival, and tumor‐like anomalies. We aim the classification to act as a shared reference for clinical and epidemiological studies. We welcome critical evaluations of the definitions and classification and will regularly update the classification for newly recognized conditions.